Krishna Bhat
Impact in
- Geriatrics and Gerontology top 0.2%
- Sirtuins and Resveratrol in Medicine
- Genetics top 1%
- Glioma Diagnosis and Treatment
Papers in
-
- Bioactive natural compounds 5
- Ubiquitin and proteasome pathways 4
- RNA Research and Splicing 4
- Oncology 21
- Cancer Cells and Metastasis 5
- Cancer-related Molecular Pathways 5
- Co-authors
- John M. Pezzuto (15 shared papers)Aiwen Jin (5 shared papers)Yanping Zhang (4 shared papers)Jerome W. Kosmeder (2 shared papers)Koji Itahana (3 shared papers)Sheila A. Dugan (1 shared paper)Yoko Itahana (2 shared papers)Theresa Allio (1 shared paper)
- Journals
- Neuro-Oncology (10 papers)Oncotarget (4 papers)Frontiers in Oncology (3 papers)Cancer Cell (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Krishna Bhat
67 papers receiving 5.5k citations
Peers
Comparison fields: 5 of 144
- Geriatrics and Gerontology 600
- Genetics 597
- Oncology 1.4k
- Cancer Research 757
- Biochemistry 293
Countries citing papers authored by Krishna Bhat
This map shows the geographic impact of Krishna Bhat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishna Bhat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishna Bhat more than expected).
Fields of papers citing papers by Krishna Bhat
This network shows the impact of papers produced by Krishna Bhat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishna Bhat. The network helps show where Krishna Bhat may publish in the future.
Co-authors
The 25 scholars most cited alongside Krishna Bhat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 468 | |
| 2 | 2001 | 441 | |
| 3 | 2003 | 381 | |
| 4 | 2001 | 348 | |
| 5 | 2002 | 331 | |
| 6 | 2011 | 305 | |
| 7 | Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. | 2001 | 298 |
| 8 | 2007 | 258 | |
| 9 | 2004 | 217 | |
| 10 | 2007 | 195 | |
| 11 | 2005 | 186 | |
| 12 | 2010 | 178 | |
| 13 | 2015 | 148 | |
| 14 | 2019 | 148 | |
| 15 | 2014 | 142 | |
| 16 | 2001 | 141 | |
| 17 | 2004 | 136 | |
| 18 | 2011 | 123 | |
| 19 | 2016 | 121 | |
| 20 | Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells. | 2001 | 107 |
About Krishna Bhat
Krishna Bhat is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Pulmonary and Respiratory Medicine, having authored 72 papers that have together received 5.7k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (20 papers), Cancer Cells and Metastasis (5 papers), Ferroptosis and cancer prognosis (5 papers), Cancer-related Molecular Pathways (5 papers), Bioactive natural compounds (5 papers), Ubiquitin and proteasome pathways (4 papers), Immune cells in cancer (4 papers) and RNA Research and Splicing (4 papers). The work is most often cited by research in Geriatrics and Gerontology (600 citations), Genetics (597 citations), Oncology (1.4k citations), Cancer Research (757 citations) and Biochemistry (293 citations). Krishna Bhat has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include John M. Pezzuto, Aiwen Jin, Yanping Zhang, Jerome W. Kosmeder, Koji Itahana, Sheila A. Dugan, Yoko Itahana, Theresa Allio, William Burkhart and Yue Xiong. Their work appears in journals such as Neuro-Oncology, Oncotarget, Frontiers in Oncology, Cancer Cell and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.